Global Aquaculture Vaccine Market

Aquaculture Vaccine Market Size, Share, Growth Analysis, By Product(Attenuated Live Vaccines, Inactivated Vaccines), By Application(bacterial infections, viral infections), By Route of administration(injection, immersion) - Industry Forecast 2024-2031


Report ID: SQMIG35J2053 | Region: Global | Published Date: February, 2024
Pages: 242 | Tables: 94 | Figures: 76

Aquaculture Vaccine Market Insights

Aquaculture Vaccine Market size was valued at USD 199.63 million in 2019 and is poised to grow from USD 214.6 million in 2023 to USD 384.64 million by 2031, growing at a CAGR of 7.6% in the forecast period (2024-2031).

Owing to the rise in the cases of bacterial and viral illnesses among aquaculture species, there will be expansion of aquaculture production globally, and the rise in the use of vaccines by aquaculture producers. Innovative vaccines being developed and released to treat various viral illnesses in aquaculture species is supporting the market's revenue growth. For instance, in Greece, the Icthiovac VR/PD injectable vaccine against Vibriosis and Pasteurellosis was introduced by Hipra in March 2018. In addition to the aforementioned characteristics, the market will see growth during the projected years due to increased funding for the study and development of novel aquaculture vaccines.

The market is anticipated to be driven by increased aquaculture output, a high incidence of infectious illnesses in the aquaculture industry, and rising consumer demand for food items produced from aquatic animals. The market has seen a shift away from live attenuated vaccines toward DNA vaccines, and it is quickly embracing recombinant vaccines as well. A large number of influential players in the aquaculture vaccines industry as well as other areas of the animal and human health industries redirected their resources to produce essential goods and supplies. For instance, Zoetis revealed during the publication of its Q3 earnings that its sales increased by 13% from the same period the year before. The recently released parasiticide for companion animals and Zoetis' important dermatological portfolio were the main drivers of performance.

Around 219 instances of infectious illnesses were reported in the fresh aquaculture sector between 2016 and 2019, according to the Aquaculture Research & Development journal. The majority (74.88%) of these cases (7.80%) were caused by parasites, 12.80% by bacteria, 1.83% by viral, and 10.50% by a combination of parasitic and bacterial infections. Consequently, it is anticipated that such a high frequency of infectious illnesses would increase the need for vaccinations, thereby boosting market development.

US Aquaculture Vaccine Market is poised to grow at a sustainable CAGR for the next forecast year.

Market snapshot - 2024-2031

Global Market Size

USD 199.63 million

Largest Segment

Injection

Fastest Growth

Injection

Growth Rate

7.6% CAGR

Global Aquaculture Vaccine Market ($ Bn)
Country Share for North America Region (%)
Global Aquaculture Vaccine Market By Route of administration ($ Bn)
Global Aquaculture Vaccine Market By Route of administration (%)

To get more reports on the above market click here to Buy The Report

Aquaculture Vaccine Market Segmental Analysis

The global aquaculture vaccines market is divided by the product, intended use, administration route, and region. According to the product, the market is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. Based on application, the market is segmented into bacterial infections, viral infections, fungal infections, and parasitic infections. Based on route of administration, the market is segmented into injection, immersion, spray, and oral. Based on region, the market is segmented into North America, Latin America, Europe, Asia Pacific, and MEA.

Aquaculture Vaccine Market Analysis by Vaccine

In 2021, activated vaccines retained the biggest market share (34.89%). Large amounts of the disease-causing microorganisms are fermented to create inactivated bacterial and viral vaccines. Then, inactivating chemicals like formalin are used to eliminate all the germs. These inactivated organisms nevertheless have their fundamental structure, original antigen properties, and form, which causes an immune response.

Aquaculture Vaccine Market Analysis by Application

In 2021, the sector including microorganisms had the highest proportion (43.94%). The USDA's Aquatic Animal Health Research has determined that bacterial species from more than 20 genera are the primary causes of aquatic illnesses. They have an impact on more than 20 species of freshwater and marine fish. Aquatic infections are thought to be responsible for hundreds of millions of dollars in yearly economic losses in the aquaculture sector.

During the projection period, the viral category is anticipated to grow at the quickest CAGR of 8.74%. According to research by the Responsible Use of Medicines in Agriculture Alliance (RUMA), Atlantic salmon, rainbow trout, and Atlantic cod are the main fish species raised through aquaculture that are routinely immunized. These species are frequently afflicted by the viral illnesses Salmon Pancreas Disease (SPD), IPN, and ISA, which are all caused by viruses.

Aquaculture Vaccine Market Analysis by Route of Administration

In 2021, the injected segment had the most share (36.73%). The first DNA vaccine approved in Canada for protection against IHNV in healthy salmonid fish is called Apex-IHN by Elanco. Aquaculture vaccines providing protection against a number of illnesses, such as furunculosis, vibriosis, cold-water vibriosis, winter sore, IPN, and infectious salmon anemia, are part of Zoetis's Alpha Ject portfolio (ISA).

The oral category is anticipated to grow at a CAGR of 8.7% during the projected period, which is the highest. Compared to alternative delivery methods, oral immunization provides a number of benefits. The method is suitable for mass vaccination since it is non-invasive, doesn't involve handling the fish, and is simple to use. This helps the segment's growth.

Global Aquaculture Vaccine Market By Route of administration, 2023 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Aquaculture Vaccine Market Regional Insights

In terms of revenue, Europe held the largest market share of more than 25.0% in 2021. Owing to stimulating efforts made by the public and corporate sectors, Europe currently controls the aquaculture vaccines market. The growing human concern about the occurrence of antimicrobial resistance will also contribute to the market expansion for aquaculture vaccines in the area over the course of the forecast year. The use of autogenous vaccinations is governed by clear regulations provided by the Norwegian Medicines Agency. Additionally, autogenous vaccinations should only be used when commercial vaccines are unavailable or do not provide adequate protection. Under the 7th Framework Program, the European Commission funded a significant cooperative initiative to support the aquaculture industry.

The aquaculture vaccines market is anticipated to have considerable expansion as consumer demand increases in Asia Pacific. Furthermore, it is expected that in the next few years, the aquaculture vaccines market would rise significantly in the area due to the expansion of the aquaculture sector and supporting government efforts.

Global Aquaculture Vaccine Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Aquaculture Vaccine Market Dynamics

Aquaculture Vaccine Market Drivers

Rise in Disease Outbreak from Consuming Seafood to Boost Demand for Aquaculture Vaccine in Global Market

  • The market for aquaculture vaccines is expanding as a result of an increase in fish mortality brought on by outbreaks of certain diseases. For instance, a disease outbreak caused by Pasteurella Skyensis infection at two fish farms on the Isle of Lewis resulted in the death of almost 125,000 salmon in October 2017. The need for animal protein, government support for aquaculture vaccination programs, and an increase in the usage of aquaculture vaccines in both developed and developing countries are also expected to drive the market for aquaculture vaccines over the coming years. Additionally, throughout the projection period, the global aquaculture vaccine market would benefit significantly from the rise in international trade of aquaculture species.

Aquaculture Vaccine Market Restraints

Risks associated with Handling and Administering the Vaccine to Hinder Market Growth

  • The creation of inexpensive adjuvants and antigens that must adhere to environmental and regulatory requirements may have an impact on the market share for aquaculture vaccines. The sales of vaccinations are hampered by this.
  • Aside from that, the need for highly experienced people to administer the vaccination, significant handling concerns, and the possibility of fungal infections would hinder the sales of aquaculture vaccines.

Request Free Customization of this report to help us to meet your business objectives.

Aquaculture Vaccine Market Competitive Landscape

To stay competitive, vendors make investments in new product launches, geographic expansions, alliances, and acquisitions. Given the large number of startups looking for possibilities in this industry, the market is anticipated to grow extremely competitive. For instance, Elanco relocated its worldwide headquarters to Indiana, United States, in December 2020. The company's Innovation, Portfolio, & Productivity (IPP) strategy was strengthened by this, and it assisted in creating a center of excellence for Elanco's upcoming footprint consolidation. In addition, Merck purchased IdentiGEN in August 2020. The company's line of livestock and aquaculture products was expanded as a result.

Aquaculture Vaccine Market Top Player's Company Profiles

  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • Hipra
  • Ceva Sante Animale
  • Vaxxinova
  • AquaBounty Technologies
  • Benchmark Holdings plc
  • Pharmaq AS
  • Bluestar Adisseo Co.
  • Genetech Biotechnology
  • Hendrix Genetics BV
  • Nisseiken Co. Ltd.
  • Tecnovax SA
  • Fish Vet Group
  • Novartis Animal Health
  • Intervet Inc.
  • Europharma AS
  • Provaxs Biotek Inc.
  • Vaki Aquaculture Systems Ltd.

Aquaculture Vaccine Market Recent Developments

  • In September 2020, Virbac, an animal health firm with a focus on R&D biology, revealed that it had acquired a variety of tilapia vaccines from Ictyogroup. In addition to this transaction, the two businesses have agreed to work together to create fresh formulations and vaccines for the Aqua Virbac division. In Africa, Asia, and Latin America, this deal is anticipated to make available the full and cutting-edge spectrum of tilapia vaccinations. With the help of this strategy, the business was able to enhance its current portfolio and increase its client base in underdeveloped nations.

Aquaculture Vaccine Key Market Trends

  • As a result of global technological improvements, there will be more chances for product innovation and development, an increase in the prevalence of aquaculture illnesses, and more public-private support for focused research initiatives. Future technological and biotechnological advancements in diagnostics and therapeutics in developing regions, as well as rising per-capita health care spending, will all contribute to the market's growth rate. In addition, there will be an increase in the number of strategic alliances, internet penetration rates, concerns about the spread of animal diseases to humans, and the number of strategic alliances overall.

Aquaculture Vaccine Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Co-relates, and Analyses the Data collected utilizing Primary Exploratory Research backed by the robust Secondary Desk research.

According to our global aquaculture vaccine market analysis, it is estimated that aquaculture output will increase internationally and that aquaculture producers will use vaccines more frequently as a result of the growth in bacterial and viral infections among aquaculture species. Aquatic animal-borne zoonotic illnesses provide a serious threat to human health. Emerging disease epidemics will inevitably continue to occur around the planet in the ensuing decades. Animal vaccinations can therefore be extremely important in containing new illnesses.

Report Metric Details
Market size value in 2023 USD 199.63 million
Market size value in 2031 USD 384.64 million
Growth Rate 7.6%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines
  • Application
    • bacterial infections, viral infections, fungal infections, and parasitic infections
  • Route of administration
    • injection, immersion, spray, and oral
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Zoetis Inc.
  • Merck Animal Health
  • Elanco Animal Health
  • Hipra
  • Ceva Sante Animale
  • Vaxxinova
  • AquaBounty Technologies
  • Benchmark Holdings plc
  • Pharmaq AS
  • Bluestar Adisseo Co.
  • Genetech Biotechnology
  • Hendrix Genetics BV
  • Nisseiken Co. Ltd.
  • Tecnovax SA
  • Fish Vet Group
  • Novartis Animal Health
  • Intervet Inc.
  • Europharma AS
  • Provaxs Biotek Inc.
  • Vaki Aquaculture Systems Ltd.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Aquaculture Vaccine Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Aquaculture Vaccine Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Aquaculture Vaccine Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Aquaculture Vaccine Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Aquaculture Vaccine Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Aquaculture Vaccine Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Aquaculture Vaccine Market size was valued at USD 199.63 million in 2019 and is poised to grow from USD 214.6 million in 2023 to USD 384.64 million by 2031, growing at a CAGR of 7.6% in the forecast period (2024-2031).

To stay competitive, vendors make investments in new product launches, geographic expansions, alliances, and acquisitions. Given the large number of startups looking for possibilities in this industry, the market is anticipated to grow extremely competitive. For instance, Elanco relocated its worldwide headquarters to Indiana, United States, in December 2020. The company's Innovation, Portfolio, & Productivity (IPP) strategy was strengthened by this, and it assisted in creating a center of excellence for Elanco's upcoming footprint consolidation. In addition, Merck purchased IdentiGEN in August 2020. The company's line of livestock and aquaculture products was expanded as a result. 'Zoetis Inc.', 'Merck Animal Health', 'Elanco Animal Health', 'Hipra', 'Ceva Sante Animale', 'Vaxxinova', 'AquaBounty Technologies', 'Benchmark Holdings plc', 'Pharmaq AS', 'Bluestar Adisseo Co.', 'Genetech Biotechnology', 'Hendrix Genetics BV', 'Nisseiken Co. Ltd.', 'Tecnovax SA', 'Fish Vet Group', 'Novartis Animal Health', 'Intervet Inc.', 'Europharma AS', 'Provaxs Biotek Inc.', 'Vaki Aquaculture Systems Ltd.'

The market for aquaculture vaccines is expanding as a result of an increase in fish mortality brought on by outbreaks of certain diseases. For instance, a disease outbreak caused by Pasteurella Skyensis infection at two fish farms on the Isle of Lewis resulted in the death of almost 125,000 salmon in October 2017. The need for animal protein, government support for aquaculture vaccination programs, and an increase in the usage of aquaculture vaccines in both developed and developing countries are also expected to drive the market for aquaculture vaccines over the coming years. Additionally, throughout the projection period, the aquaculture vaccine market would benefit significantly from the rise in international trade of aquaculture species.

As a result of technological improvements, there will be more chances for product innovation and development, an increase in the prevalence of aquaculture illnesses, and more public-private support for focused research initiatives. Future technological and biotechnological advancements in diagnostics and therapeutics in developing regions, as well as rising per-capita health care spending, will all contribute to the market's growth rate. In addition, there will be an increase in the number of strategic alliances, internet penetration rates, concerns about the spread of animal diseases to humans, and the number of strategic alliances overall.

In terms of revenue, Europe held the largest market share of more than 25.0% in 2021. Owing to stimulating efforts made by the public and corporate sectors, Europe currently controls the aquaculture vaccines market. The growing human concern about the occurrence of antimicrobial resistance will also contribute to the market expansion for aquaculture vaccines in the area over the course of the forecast year. The use of autogenous vaccinations is governed by clear regulations provided by the Norwegian Medicines Agency. Additionally, autogenous vaccinations should only be used when commercial vaccines are unavailable or do not provide adequate protection. Under the 7th Framework Program, the European Commission funded a significant cooperative initiative to support the aquaculture industry.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Aquaculture Vaccine Market

Product ID: SQMIG35J2053

$5,300
BUY NOW GET FREE SAMPLE